The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Inhibition of Serotonin But Not Norepinephrine Transport during Development Produces Delayed, Persistent Perturbations of Emotional Behaviors in Mice
Open accessAbstract
Serotonin (5-HT) acts as a neurotransmitter, but also modulates brain maturation during early development. The demonstrated influence of genetic variants on brain function, personality traits, and susceptibility to neuropsychiatric disorders suggests a critical importance of developmental mechanisms. However, little is known about how and when developmentally perturbed 5-HT signaling affects circuitry and resulting behavior. The 5-HT transporter (5-HTT) is a key regulator of extracellular 5-HT levels and we used pharmacologic strategies to manipulate 5-HTT function during development and determine behavioral consequences. Transient exposure to the 5-HTT inhibitors fluoxetine, clomipramine, and citalopram from postnatal day 4 (P4) to P21 produced abnormal emotional behaviors in adult mice. Similar treatment with the norepinephrine transporter (NET) inhibitor, desipramine, did not adversely affect adult behavior, suggesting that 5-HT and norepinephrine (NE) do not share the same effects on brain development. Shifting our period of treatment/testing to P90/P185 failed to mimic the effect of earlier exposure, demonstrating that 5-HT effects on adult behavior are developmentally specific. We have hypothesized that early-life perturbations of 5-HT signaling affect corticolimbic circuits that do not reach maturity until the peri-adolescent period. In support of this idea, we found that abnormal behaviors resulting from postnatal fluoxetine exposure have a post-pubescent onset and persist long after reaching adult age. A better understanding of the underlying 5-HT sensitive circuits and how they are perturbed should lead to new insights into how various genetic polymorphisms confer their risk to carriers. Furthermore, these studies should help determine whether in utero exposure to 5-HTT blocking drugs poses a risk for behavioral abnormalities in later life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162
Pezawas, L., Meyer-Lindenberg, A., Drabant, E. M., Verchinski, B. A., Munoz, K. E., Kolachana, B. S., Egan, M. F., Mattay, V. S., Hariri, A. R., & Weinberger, D. R. (2005) · Nature Neuroscience · doi:10.1038/nn1463 · Cited by 1,980 · cited 3×
“Ontogeny of behavioral abnormalities in mice exposed to PN-fluoxetine The function of corticolimbic circuitry in human subjects is sensitive to genetic variations in the 5-htt promoter region (Heinz et al., 2005; Pezawas et al., 2005).”
BackgroundNew approaches to antidepressant drug discovery: beyond monoamines
Berton, O., & Nestler, E. J. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1846 · Cited by 1,589
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“Paradoxically, this observation contrasts the effect of pharmacologic 5-HTT blockade during adulthood in which it ameliorates anxiety and depression-related behaviors in humans (Owens and Nemeroff, 1998; Berton and Nestler, 2006) and rodents (Cryan et al., 2002; Dulawa and Hen, 2005).”
BackgroundThe developmental role of serotonin: news from mouse molecular genetics
Gaspar, P., Cases, O., & Maroteaux, L. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1256 · Cited by 1,297
Effect of Neonatal Handling on Age-Related Impairments Associated with the Hippocampus
Meaney, M. J., Aitken, D. H., van Berkel, C., Bhatnagar, S., & Sapolsky, R. M. (1988) · Science · doi:10.1126/science.3340858 · Cited by 1,074
Early-Life Blockade of the 5-HT Transporter Alters Emotional Behavior in Adult Mice
Ansorge, M. S., Zhou, M., Lira, A., Hen, R., & Gingrich, J. A. (2004) · Science · doi:10.1126/science.1101678 · Cited by 817 · cited 4×
“In line with previously published data (Lira et al., 2003; Ansorge et al., 2004), no significant effects were detected for these interactions (data not shown) and groups were collapsed for sex and genotype.”
BackgroundResultSelf-citationAmygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter
Heinz, A., Braus, D. F., Smolka, M. N., Wrase, J., Puls, I., Hermann, D., Klein, S., Grüsser, S. M., Flor, H., Schumann, G., et al. (2005) · Nature Neuroscience · doi:10.1038/nn1366 · Cited by 700
Effects of Chronic Fluoxetine in Animal Models of Anxiety and Depression
Dulawa, S. C., Holick, K. A., Gundersen, B., & Hen, R. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300433 · Cited by 671
Mann, J. J., Huang, Y.-Y., Underwood, M. D., Kassir, S. A., Oppenheim, S., Kelly, T. M., Dwork, A. J., & Arango, V. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.8.729 · Cited by 613
Haydon, P. G., McCobb, D. P., & Kater, S. B. (1984) · Science · doi:10.1126/science.6093252 · Cited by 545
Cases, O., Vitalis, T., Seif, I., De Maeyer, E., Sotelo, C., & Gaspar, P. (1996) · Neuron · doi:10.1016/s0896-6273(00)80048-3 · Cited by 514
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492
Mice lacking the norepinephrine transporter are supersensitive to psychostimulants
Xu, F., Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Bohn, L. M., Miller, G. W., Wang, Y.-M., & Caron, M. G. (2000) · Nature Neuroscience · doi:10.1038/74839 · Cited by 464
Dulawa, S. C., & Hen, R. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.017 · Cited by 430
Ontogeny of the Serotonergic System in the Rat: Serotonin as a Developmental Signala
LAUDER, J. M. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb16891.x · Cited by 405
Lira, A., Zhou, M., Castanon, N., Ansorge, M. S., Gordon, J. A., Francis, J. H., Bradley-Moore, M., Lira, J., Underwood, M. D., Arango, V., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00696-6 · Cited by 391
Self-citationLewis, D. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00277-1 · Cited by 388
Davey, C. G., Yücel, M., & Allen, N. B. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.04.016 · Cited by 377
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
Heurteaux, C., Lucas, G., Guy, N., El Yacoubi, M., Thümmler, S., Peng, X.-D., Noble, F., Blondeau, N., Widmann, C., Borsotto, M., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1749 · Cited by 374
Long-term behavioural and molecular alterations associated with maternal separation in rats
Lippmann, M., Bress, A., Nemeroff, C. B., Plotsky, P. M., & Monteggia, L. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05522.x · Cited by 355
Neonatal Antidepressant Exposure has Lasting Effects on Behavior and Serotonin Circuitry
Maciag, D., Simpson, K. L., Coppinger, D., Lu, Y., Wang, Y., Lin, R. C. S., & Paul, I. A. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300823 · Cited by 302
Salichon, N., Gaspar, P., Upton, A. L., Picaud, S., Hanoun, N., Hamon, M., De Maeyer, E., Murphy, D. L., Mössner, R., Lesch, K. P., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-03-00884.2001 · Cited by 265
Parsey, R. V., Hastings, R. S., Oquendo, M. A., Hu, X., Goldman, D., Huang, Y.-Y., Simpson, N., Arcement, J., Huang, Y., Ogden, R. T., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.48 · Cited by 262
Newman, T. K., Syagailo, Y. V., Barr, C. S., Wendland, J. R., Champoux, M., Graessle, M., Suomi, S. J., Higley, J. D., & Lesch, K.-P. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.012 · Cited by 258
Toward a molecular architecture of personality
Reif, A., & Lesch, K.-P. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00267-x · Cited by 253
Genetic perspectives on the serotonin transporter
Murphy, D. L., Li, Q., Engel, S., Wichems, C., Andrews, A., Lesch, K.-P., & Uhl, G. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00622-0 · Cited by 213
Caccia, S., Cappi, M., Fracasso, C., & Garattini, S. (1990) · Psychopharmacology · doi:10.1007/bf02244004 · Cited by 207
A new animal model of endogenous depression: A summary of present findings
Vogel, G., Neill, D., Hagler, M., & Kors, D. (1990) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80164-2 · Cited by 207
Barr, C. S., Newman, T. K., Schwandt, M., Shannon, C., Dvoskin, R. L., Lindell, S. G., Taubman, J., Thompson, B., Champoux, M., Lesch, K. P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403763101 · Cited by 205
Neurodevelopmental origins of depressive disorders
Ansorge, M. S., Hen, R., & Gingrich, J. A. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.11.006 · Cited by 193
Self-citationRebsam, A., Seif, I., & Gaspar, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-19-08541.2002 · Cited by 190
Kalueff, A. V., Fox, M. A., Gallagher, P. S., & Murphy, D. L. (2007) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2006.00270.x · Cited by 187
Altered fear circuits in 5-HT1A receptor KO mice
Gross, C., Santarelli, L., Brunner, D., Zhuang, X., & Hen, R. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01041-6 · Cited by 181
Kim, C., Hahn, M. K., Joung, Y., Anderson, S. L., Steele, A., Mazei‐Robison, M. S., Gizer, I. R., Teicher, M. H., Cohen, B. M., Robertson, D., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510836103 · Cited by 167
Programming social, cognitive, and neuroendocrine development by early exposure to novelty
Tang, A. C., Akers, K. G., Reeb, B. C., Romeo, R. D., & McEwen, B. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607374103 · Cited by 134
Vitalis, T., Cases, O., Callebert, J., Launay, J., Price, D. J., Seif, I., & Gaspar, P. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980406)393:2<169::aid-cne3>3.0.co;2-0 · Cited by 131
Carrasco, J., & Sandner, C. (2005) · International journal of clinical practice · doi:10.1111/j.1368-5031.2005.00681.x · Cited by 119
The serotonin transporter and depression
Owens, M. J., & Nemeroff, C. B. (1998) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1998)8:1+<5::aid-da2>3.0.co;2-i · Cited by 118
Breastfeeding During Maternal Antidepressant Treatment With Serotonin Reuptake Inhibitors
Berle, J. Ø., Steen, V. M., Aamo, T. O., Breilid, H., Zahlsen, K., & Spigset, O. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0911 · Cited by 117
Significance of Adolescent Neurodevelopment for the Neural Circuitry of Bipolar Disorder
Blumberg, H. P., Kaufman, J., Martin, A., Charney, D. S., Krystal, J. H., & Peterson, B. S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1308.048 · Cited by 107
Hirano, K., Kimura, R., Sugimoto, Y., Yamada, J., Uchida, S., Kato, Y., Hashimoto, H., & Yamada, S. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706108 · Cited by 101
Functional polymorphisms of the brain serotonin synthesizing enzyme tryptophan hydroxylase-2
Zhang, X., Beaulieu, J., Gainetdinov, R. R., & Caron, M. G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5417-4 · Cited by 95
The Pharmacokinetics of Sertraline Excretion Into Human Breast Milk
Stowe, Z. N., Hostetter, A. L., Owens, M. J., Ritchie, J., Sternberg, K., Cohen, L. S., & Nemeroff, C. B. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0114 · Cited by 91
Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders
Wolterink, G., Daenen, L. E. W. P. M., Dubbeldam, S., Gerrits, M. A. F. M., van Rijn, R. S., Kruse, C. G., Heijden, J. A. M. V. D., & van Ree, J. M. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00138-3 · Cited by 85
Kinetics of citalopram in test animals; drug exposure in safety studies
Overø, K. F. (1982) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(82)80180-2 · Cited by 78
Functional polymorphisms in dopamine and serotonin pathway genes
D’Souza, U. M., & Craig, I. (2005) · Human Mutation · doi:10.1002/humu.20278 · Cited by 75
Development of the norepinephrine transporter in the rat CNS
Sanders, J. D., Happe, H. K., Bylund, D., & Murrin, L. C. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.014 · Cited by 74
Effect of Antidepressant Drugs in Mice Lacking the Norepinephrine Transporter
Dziedzicka‐Wasylewska, M., Faron‐Górecka, A., Kuśmider, M., Drozdowska, E., Rogóż, Z., Siwanowicz, J., Caron, M. G., & Bönisch, H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301064 · Cited by 72
Suckow, R. F., Zhang, M. F., & Cooper, T. B. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1756 · Cited by 66
Estimates of nursing infant daily dose of fluoxetine through breast milk
Suri, R., Stowe, Z. N., Hendrick, V. C., et al. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01368-9 · Cited by 60
Behavioral Characteristics of Mice with Genetic Knockout of Monoamine Oxidase Type A
Popova, N. K., Skrinskaya, Y. A., Amstislavskaya, T. G., Vishnivetskaya, G. B., Seif, I., & de Meier, E. (2001) · Neuroscience and Behavioral Physiology · doi:10.1023/a:1012364910091 · Cited by 55
Eschalier, A., Fialip, J., Spreux‐Varoquaux, O., Makambila, M. C., Marty, H., & Bastide, P. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24114-3 · Cited by 40
The critical window of brain development from susceptive to insusceptive
Feng, P., Ma, Y., & Vogel, G. W. (2001) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00158-4 · Cited by 38
Weigmann, H., Härtter, S., Bagli, M., & Hiemke, C. (2000) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(00)00098-5 · Cited by 35
Keller, N. R., Diedrich, A., Appalsamy, M., Miller, L. C., Caron, M. G., McDonald, M. P., Shelton, R. C., Blakely, R., & Robertson, D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.01.008 · Cited by 31
Tb, C., Allen, D. L., & Gm, S. (1975) · PubMed · Cited by 31
Cited by
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. D., Shanahan, F., Dinan, T. G., & Cryan, J. F. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.77 · Cited by 1,893
SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Kristensen, A. S., Andersen, J., Jørgensen, T. N., Sørensen, L., Eriksen, J., Loland, C. J., Strømgaard, K., & Gether, U. (2011) · Pharmacological Reviews · doi:10.1124/pr.108.000869 · Cited by 864
Geller, D. A., & March, J. (2012) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2011.09.019 · Cited by 514
Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders
Croen, L. A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.73 · Cited by 510
“In rodent models, transient inhibition of the serotonin transporter by the SSRI fluoxetine during early brain development produced abnormal emotional behaviors in adult animals, indicating a critical role for serotonin in the maturation of brain systems.(27,28,55,56) The effects of early exposure to SSRIs mimic the be…”
BackgroundThe Serotonin-1A Receptor in Anxiety Disorders
Akimova, E., Lanzenberger, R., & Kasper, S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.03.012 · Cited by 360
Metadata
- Authors
- Ansorge, M. S., Morelli, E., & Gingrich, J. A.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-01-02
- Volume
- 28
- Issue
- 1
- Pages
- 199-207
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2038771513
- Cited by
- 301
- References
- 57
- FWCI
- 10.62
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.